25.8 C
California
Thursday, October 22, 2020

Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant

Budrul Chukrut | LightRocket | Getty Images

The study of Johnson & Johnson’s Covid-19 vaccine has been paused due to an unexplained illness in a study participant.

A document sent to outside researchers running the 60,000-patient clinical trial states that a “pausing rule” has been met, that the online system used to enroll patients in the study has been closed, and that the data and safety monitoring board — an independent committee that watches over the safety of patients in the clinical trial — would be convened. The document was obtained by STAT.

Contacted by STAT, J&J confirmed the study pause, saying it was due to “an unexplained illness in a study participant.” The company declined to provide further details.

“We must respect this participant’s privacy. We’re also learning more about this participant’s illness, and it’s important to have all the facts before we share additional information,” the company said in a statement.

J&J emphasized that so-called adverse events — illnesses, accidents, and other bad medical outcomes — are an expected part of a clinical study, and also emphasized the difference between a study pause and a clinical hold, which is a formal regulatory action that can last much longer. The vaccine study is not currently under a clinical hold. J&J said that while it normally communicates clinical holds to the public, it does not usually inform the public of study pauses.

The data and safety monitoring board, or DSMB, convened late Monday to review the case. J&J said that in cases like this “it is not always immediately apparent” whether the participant who experienced an adverse event received a study treatment or a placebo.

Though clinical trial pauses are not uncommon — and in some cases last only a few days — they are generating outsized attention in the race to test vaccines against SARS-CoV-2, the virus that causes Covid-19.

Given the size of Johnson & Johnson’s trial, it’s not surprising that study pauses could occur, and another could happen if this one resolves, a source familiar with the study said.

“If we do a study of 60,000 people, that is a small village,” the source said. “In a small village there are a lot of medical events that happen.”

On Sept. 8, a large study of another Covid-19 vaccine being developed by AstraZeneca and Oxford University was put on hold because of a suspected adverse reaction in a patient in the United Kingdom. It’s believed that the patient had transverse myelitis, a spinal cord problem. Studies of the vaccine resumed roughly a week after it was paused in the United Kingdom, and have since been restarted in other countries as well. It remains on hold, however, in the United States. 

Johnson and Johnson began enrolling volunteers in its Phase 3 study on Sept. 23. Researchers planned to enroll 60,000 participants in the United States and other countries.

Speak Your Mind

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Get in Touch

211FansLike
35FollowersFollow
41FollowersFollow

Recommend for You

‘Out of control’: European leaders scramble to control the second wave, with a state of emergency and lockdowns

A nurse gets ready to enter a room to take care of a patient infected with Covid-19 at the intensive care unit of the...

Democrats Attack Trump On Twitter Following Report He Paid $750 In Taxes

Topline A bombshell report in the New York Times detailing President Trump's tax information dating back two decades led to a social media onslaught...

Special Report: Plastic Pandemic: COVID-19 Trashed The Recycling Dream

The coronavirus pandemic has sparked a rush for plastic.From Wuhan to New York, demand for face shields, gloves, takeaway food containers and bubble wrap...

Dr. Fauci says his kids aren’t coming home for Thanksgiving as Americans ‘sacrifice’ holiday gatherings to stay safe from coronavirus

Director of the National Institute for Allergy and Infectious Diseases Dr. Anthony Fauci testifies before the House Committee on Energy and Commerce on the...

Trump Repeats Claim He Is ‘Immune’ To Covid As He Proposes Kissing Audience Members At Packed Florida Airport Rally

Topline One week after leaving Walter Reed hospital while still potentially contagious with Covid-19, President Donald Trump returned to in-person campaigning in earnest on...

Related Articles

Then They Came For Me – And There Was...

“Then they came for me - and there was no one left to speak...

Colgate’s ‘Black Person Toothpaste’—A Market Leader In China—Is Under...

TOPLINE Colgate has announced a review of top-selling Chinese toothpaste brand Darlie, whose name...

Air India: Choice is between privatising or closing it...

NEW DELHI: Minister for civil aviation Hardeep Singh Puri on Tuesday told the Rajya...

Match Of The Day Continues Technological Legacy With New...

MOTD presenter Gary Lineker with pundits Ruud Gullit and...